# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-26-001581
Filing Date
2026-03-23
Accepted
2026-03-23 07:09:07
Documents
111
Period of Report
2025-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 20-F | zk2634707.htm iXBRL | 20-F | 3497494
2 | EXHIBIT 1.1 | exhibit_1-1.htm | EX-1.1 | 186035
3 | EXHIBIT 2.2 | exhibit_2-2.htm | EX-2.2 | 51736
4 | EXHIBIT 8.1 | exhibit_8-1.htm | EX-8.1 | 4074
5 | EXHIBIT 12.1 | exhibit_12-1.htm | EX-12.1 | 13422
6 | EXHIBIT 12.2 | exhibit_12-2.htm | EX-12.2 | 12980
7 | EXHIBIT 13.1 | exhibit_13-1.htm | EX-13.1 | 4471
8 | EXHIBIT 13.2 | exhibit_13-2.htm | EX-13.2 | 4459
9 | EXHIBIT 15.1 | exhibit_15-1.htm | EX-15.1 | 3124
15 | GRAPHIC | image0.jpg | GRAPHIC | 38360
16 | GRAPHIC | image2.jpg | GRAPHIC | 204156
17 | GRAPHIC | image3.jpg | GRAPHIC | 12594
18 | GRAPHIC | image00001.jpg | GRAPHIC | 38360
| Complete submission text file | 0001178913-26-001581.txt |  | 15150465

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL SCHEMA FILE | blrx-20251231.xsd | EX-101.SCH | 136572
11 | XBRL CALCULATION FILE | blrx-20251231_cal.xml | EX-101.CAL | 74724
12 | XBRL DEFINITION FILE | blrx-20251231_def.xml | EX-101.DEF | 312608
13 | XBRL LABEL FILE | blrx-20251231_lab.xml | EX-101.LAB | 1098870
14 | XBRL PRESENTATION FILE | blrx-20251231_pre.xml | EX-101.PRE | 513661
115 | EXTRACTED XBRL INSTANCE DOCUMENT | zk2634707_htm.xml | XML | 3024776

Mailing Address 2 HAMAAYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN Israel ISRAEL
Business Address 2 HAMAAYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN Israel ISRAEL 972-8-642-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-35223 | Film No.: 26779874
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)